Adjuvant Nivolumab Tops Ipilimumab in Melanoma

Longer recurrence - free survival for stage IIIB, IIIC, IV melanoma
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Conference News, Source Type: news